Vimarsana
Biggest News Aggregation in the World

Pract Res Clin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pract Res Clin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pract Res Clin Today - Breaking & Trending Today

Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process - Vimarsana News

Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process

/PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces completion of the Human...

Pain Management Remains Challenging for Patients with Fibromyalgia - Vimarsana News

Pain Management Remains Challenging for Patients with Fibromyalgia

Results of a database search reveal the management of pain symptoms remains a continued source of frustration and an unmet need for patients with fibromyalgia.

Pharmacist-led Post-Cardiovascular Surgery Outpatient Glycemic Management - Vimarsana News

Pharmacist-led Post-Cardiovascular Surgery Outpatient Glycemic Management

Pharmacist-led post-cardiovascular surgery outpatient glycemic management services help reduce hospital readmissions and sternal wound infections in patients with uncontrolled diabetes who recently underwent an interventional cardiology procedure.

Proton Pump Inhibitors in Heart Disease Patients - Vimarsana News

Proton Pump Inhibitors in Heart Disease Patients

Elucidating the mechanisms by which PPIs increase cardiovascular events, thereby reminding clinicians to rationally prescribe PPIs. Learn more inside.

AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age - Vimarsana News

AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted a supplemental New Drug Application (sNDA) for linaclotide (LINZESS®) to the U.S....